Recombinant Anti-CC531 × Anti-CD8 Bispecific Antibody (CrossMab) (CAT#: CROSS-L032)
Recombinant Anti-CC531 × Anti-CD8 Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgG shaped entity that binds each ligand with one arm. It was designed for the treatment of Colon carcinoma.
Specific Inquiry
Specifications
- Target
- CC531 & CD8
- Type
- CrossMab
- Species Reactivity
- Rat
- Target 1
- CC531
- Host Species 1
- Mouse
- Target 2
- CD8
- Host Species 2
- Mouse
- Application
- FuncS, Promising therapeutic agent
- Related Disease
- Colon carcinoma
Target
- Target 1
- CC531
- Gene ID
- 116568
- UniProt ID
- P07314
- Alternative Names
- Ggt; Ggtp; GGLUT
- Target 2
- CD8
- Gene ID
- 24930
- UniProt ID
- P07725
- Alternative Names
- CD8; Cd8a; CD8a molecule
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for CROSS-L032. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, Cyt, Stim, PP, Agonist
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: FuncS, IF, Neut, ELISA, FC, IP, WB
Application: ELISA, WB, BLI, SPR
Application: WB, ELISA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, IF, Block, FuncS
Application: Neut, ELISA, WB, SPR, IF, EM
Application: Neut, IHC, Activ, FuncS, IF, ELISA
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.